Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2

Affiliations

• ¹ Division of Infection and Immunity, University College London, London, UK.
• ² QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
• ³ Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
• ⁴ J. David Gladstone Institutes, San Francisco, CA, USA.
• ⁵ Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
• ⁶ Division of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
• ⁷ Epithelial Stem Cell Biology and Regenerative Medicine Laboratory, The Francis Crick Institute, London, UK.
• ⁸ MIT Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA.
• ⁹ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ¹⁰ European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.
• ¹¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹² Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹³ Howard Hughes Medical Institute, San Francisco, CA, USA.
• ¹⁴ Division of Advanced Therapies, National Institute for Biological Standards and Control, South Mimms, UK.
• ¹⁵ Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
• ¹⁶ The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁷ Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁸ Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁹ Division of Infection and Immunity, University College London, London, UK. c.jolly@ucl.ac.uk.
• ²⁰ Division of Infection and Immunity, University College London, London, UK. g.towers@ucl.ac.uk.
• ²¹ QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.
• ²² Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.
• ²³ J. David Gladstone Institutes, San Francisco, CA, USA. nevan.krogan@ucsf.edu.
• ²⁴ Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.